Fuji Chemical

Formulation Challenges in Low-Dose Fixed-Dose Combinations Developing fixed-dose combination (FDC) therapies presents unique formulation challenges, particularly when one active pharmaceutical...

Abstract Excipients are indispensable components of pharmaceutical dosage forms, significantly influencing product quality, safety, and performance. Conventional single excipients often...

See the latest edition of the Fuji Chemical Technical Newsletter: THE POLYMORPHISM CHALLENGE IN BILASTINE FORMULATION Bilastine is a second-generation,...

Abstract We report gastroretentive (GR) tablets optimized via a data-driven regression-based predictive modeling strategy to determine the optimal hydroxypropyl methylcellulose...

See the latest edition of the Fuji Chemical Technical Newsletter: Why Etoricoxib is Difficult to Formulate? Etoricoxib, a selective COX-2...

Abstract The pharmaceutical industry is increasingly adopting co-processed excipients as alternatives to conventional excipients in tablet manufacturing despite certain regulatory...

Abstract Moisture is a critical external factor affecting the powder behaviour. This work focused on the effect of moisture on...

Abstract For any drug to be therapeutically efficacious it must enter the systemic circulation and in order to do so,...

Abstract The current work uses liquisolid (LS) technology to increase the absorption efficiency and dissolution rate of the weakly water-soluble...

This year CPHI Europe opens its doors in Frankfurt at Messe Frankfurt. From 28th to 30th October you can have...